Founded in 2015 by a father-son duo with a longstanding family history of innovation, Cliintel equips growth-oriented companies across the cannabis supply chain and other emerging “vice” industries with the tools and support necessary to succeed in making their vision a reality.
Bet on the person not the deal
By focusing on the person, not the deal, Cliintel truly connects ideas, people and resources to create value. Initially concentrated on the cannabis sector, the people-driven venture capital firm empowers investors to navigate heavily regulated industries and the challenges those assets can present. Through exclusive investment knowledge and operational experience, Cliintel assists companies on the cutting edge with capital strategy, strategic partnerships, corporate governance compliance, investor relations, organizational structure and business acumen to mitigate the risks a new business faces and boost profitability.
History of the family
At Cliintel Capital, our mission is to create value for stakeholders and portfolio companies through unique funding opportunities, our deep, meaningful diligence process and strategic guidance that equips portfolio companies to grow and succeed.
- People-focused approach
- Clever creativity
Richard M Batenburg Jr
An experienced operations-oriented executive with proven success in managing all aspects of business, from strategy through tactical planning and execution, Richard Batenburg Jr. is Cliintel Capital’s chief executive officer and fund manager. In his role, Richard specializes in the
acquisition, optimization and management of businesses, with deep experience in establishing strategies to maximize profitability. In addition to his role at Cliintel, Richard serves as chairman of the board at Clear Cannabis, Inc. and holds managing positions at Batmann Consulting, Inc.; BATMANN Capital, LLC; Bonsai Cultivation; and BB Talent, LLC. Before co-founding Cliintel, Richard worked as an executive at AT&T, Comcast and Sun Microsystems, and he has founded, owned and operated businesses across different industries. He is the author of “Change is Great: BE FIRST” and received his bachelor’s degree from Colorado State University.
Chief Investment Officer
An entrepreneur and venture capitalist focused on emerging markets, specifically cannabis, Rick Batenburg is Cliintel Capital’s chief investment officer.
In this role, Rick is responsible for raising capital, structuring deals and managing deal flow, investor relations, and combining resources and capital to create meaningful value. Prior to co-founding Cliintel, Rick spent three years at Merrill Lynch as an advisor specializing in private equity and alternative investments. Rick in 2014 founded and continues to operate the Breckenridge Vipers, a semi-professional hockey team competing in the Mountain West Hockey League. Rick manages both the players and the business aspects of the team. Rick also serves on the board of directors of Global Orphan Prevention and Clear Cannabis, Inc. He received his bachelor’s degree from Nichols College.
SVP, Investor Relations
Leveraging nearly two decades experience in business development and organizational operations, she oversees all aspects of company operations and is responsible for strategizing and implementing processes and procedures to promote business scalability. Monica also helps maintain accurate and in-depth knowledge of each portfolio company’s financial community, anticipates market changes and trends that can affect profitability, and assists with outreach marketing, social activities and events. Prior to joining Cliintel, Monica served as a broker associate at Workman & Associates. She received her bachelor’s degree from Metropolitan State University and her master’s from the University of Colorado Denver.